Univariate Survival Analysis for 31 Patients with Evaluable Response After Neoadjuvant Therapy
| Parameter | P |
|---|---|
| ER expression | 0.48 |
| c-erbB-2 expression | 0.98 |
| Ki-67 proliferative index | 0.21 |
| Pathologic response | 0.34 |
| >4 positive nodes after therapy | 0.004 |
| MRFDG (PET) | 0.14 |
| Blood flow (PET) | 0.69 |
| MRFDG/flow (PET) | 0.05 |
Median follow-up = 32.5 mo.